Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
2.67M
-
Shares change
-
-80.7K
-
Total reported value, excl. options
-
$5.13M
-
Value change
-
-$314K
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$1.92
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2022
23 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q4 2022.
Journey Medical Corp - Common Stock (DERM) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.67M shares
of 17.2M outstanding shares and own 15.54% of the company stock.
Largest 10 shareholders include B. Riley Securities, Inc. (865K shares), B. Riley Financial, Inc. (865K shares), Nantahala Capital Management, LLC (226K shares), PERKINS CAPITAL MANAGEMENT INC (226K shares), AMERICAN FINANCIAL GROUP INC (180K shares), Neuberger Berman Group LLC (132K shares), FIRST MANHATTAN CO (35.3K shares), GEODE CAPITAL MANAGEMENT, LLC (29.9K shares), Cerity Partners LLC (25.4K shares), and B. Riley Wealth Advisors, Inc. (17.3K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.